Blood News and Research

RSS

InsuPad device may improve insulin therapy

A novel device is currently under development for aiding insulin analog therapy in diabetes patients, report researchers.

4 Oct 2012

RNA clue to MS disease course

Researchers say that the RNA profiles of peripheral blood mononuclear cells can identify two distinct subsets of patients with multiple sclerosis.

4 Oct 2012

Loyola oncologist named ‘Heroes of Hope’ by Leukemia Research Foundation

The Leukemia Research Foundation has named Loyola University Medical Center oncologist Dr. Tulio Rodriguez one of its "Heroes for Hope."

4 Oct 2012

New defibrillator offers advantages for young patients with congenital heart problems

A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada's special access program, this was only the third time this new type of ICD had been implanted in Canada.

4 Oct 2012

Scripps Health receives Qualcomm Foundation grant to support digital medicine research projects

Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine.

4 Oct 2012

BPA exposure can impact thyroid hormones in pregnant women and newborns

Bisphenol A (BPA), an estrogen-like compound that has drawn increased scrutiny in recent years, has been linked to changes in thyroid hormone levels in pregnant women and newborn boys, according to a new study by researchers at the University of California, Berkeley.

4 Oct 2012

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

ArjoHuntleigh announced today that it has been awarded a three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its vascular compression therapy systems.

4 Oct 2012

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.

4 Oct 2012

States ask, answer questions on health law implementation

Even as some states didn't meet the target set by the Department of Health and Human Services for submitting their "benchmark" plans regarding the health law's essential health benefits, others offered specifics about what would be covered and what plans would be their choice.

4 Oct 2012

Estrogen/progesterone treatment started soon after menopause appears safe and effective

Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida.

4 Oct 2012

Georgia Tech's ClockMe system helps older adults identify early signs of dementia

With baby boomers approaching the age of 65 and new cases of Alzheimer's disease expected to increase by 50 percent by the year 2030, Georgia Tech researchers have created a tool that allows adults to screen themselves for early signs of dementia. The home-based computer software is patterned after the paper-and-pencil Clock Drawing Test, one of health care's most commonly used screening exams for cognitive impairment.

4 Oct 2012

Assisted reproduction technology may increase risk of MS activity among women

Researchers in Argentina report that women with multiple sclerosis (MS) who undergo assisted reproduction technology (ART) infertility treatment are at risk for increased disease activity.

4 Oct 2012

Merck announces data from MK-3102 Phase IIb trial on type 2 diabetes

Merck, known as MSD outside the United States and Canada, today announced Phase IIb data for MK-3102, the company's investigational once-weekly DPP-4 inhibitor in development for the treatment of type 2 diabetes.

4 Oct 2012

American College of Surgeons Committee on Trauma develops ATLS mobile app

For the first time, first responders to emergency medical situations will have a mobile app ready for use in the field that provides up-to-date content from the Advanced Trauma Life Support Program (ATLS) developed by the Committee on Trauma (COT) of the American College of Surgeons (ACS).

4 Oct 2012

New mathematical formulas can evaluate kidney function with age

Within the framework of a Berlin cohort study, scientists from Charité - Universitätsmedizin Berlin have succeeded in developing new mathematical formulas that dependently assess kidney function with age.

4 Oct 2012

Rare study highlights anal cancer prognosis risks

The presence of palpable, clinically involved inguinal lymph nodes and male gender are both independent risk factors for poor prognosis in anal cancer, confirm the results of a UK analysis.

3 Oct 2012

Complement dysregulation underpins pre-eclampsia

Pre-eclampsia is associated with increased classical pathway activation and altered complement regulation, suggest Dutch results indicating that the extent of complement dysregulation may be related to the severity of pre-eclampsia.

3 Oct 2012

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Bone marrow transplant (also called stem cell transplant) is a medical intervention that allows a physician to deliver very high doses of chemotherapy (if needed) but more importantly, deliver a new immune system to the patient to fight a disease (such as cancer).

3 Oct 2012

Blood News and Research

InsuPad device may improve insulin therapy

RNA clue to MS disease course

Loyola oncologist named ‘Heroes of Hope’ by Leukemia Research Foundation

New defibrillator offers advantages for young patients with congenital heart problems

Scripps Health receives Qualcomm Foundation grant to support digital medicine research projects

BPA exposure can impact thyroid hormones in pregnant women and newborns

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

States ask, answer questions on health law implementation

Estrogen/progesterone treatment started soon after menopause appears safe and effective

Georgia Tech's ClockMe system helps older adults identify early signs of dementia

Assisted reproduction technology may increase risk of MS activity among women

Merck announces data from MK-3102 Phase IIb trial on type 2 diabetes

American College of Surgeons Committee on Trauma develops ATLS mobile app

New mathematical formulas can evaluate kidney function with age

Rare study highlights anal cancer prognosis risks

Complement dysregulation underpins pre-eclampsia

Haploidentical bone marrow transplants for sickle cell disease: an interview with Dr. Javier Bolaños Meade

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News